Methods for assessing the interaction of agents with 5-hydroxytryptamine neurons and receptors in the brain.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000166:cytology / Q000187:drug effects*; D002415:Cats; D002645:Chickens; D004567:Electrodes, Implanted; D004569:Electroencephalography; D010134:Fenclonine / Q000494:pharmacology; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008526:Medulla Oblongata / Q000378:metabolism; D008784:Methysergide / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects*; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D010640:Phenothiazines / Q000494:pharmacology; D011149:Pons / Q000378:metabolism; D011807:Quinolizines / Q000494:pharmacology; D011955:Receptors, Drug / Q000187:drug effects*; D012701:Serotonin / Q000378:metabolism* / Q000494:pharmacology; D012702:Serotonin Antagonists; D012890:Sleep / Q000187:drug effects; D013997:Time Factors; D014364:Tryptophan / Q000494:pharmacology
D010640:Phenothiazines; D011807:Quinolizines; D011955:Receptors, Drug; D012702:Serotonin Antagonists; D012701:Serotonin; D014364:Tryptophan; D008238:Lysergic Acid Diethylamide; D006916:5-Hydroxytryptophan; D010134:Fenclonine; D009638:Norepinephrine; D008784:Methysergide